By Max A. Cherney, Tech reporter, MarketWatch

Canada-based Canopy Growth Corp. has withdrawn a trademark it filed in August for the phrase “Chronic By Dre,” according to a company spokesman.

“Chronic By Dre” refers to the 1992 album by rapper and music mogul Andre Young, also known as Dr. Dre. It also works as a hat-tip to “CBD” or cannabidiol, a non-psychoactive substance found in marijuana and hemp plants.

In a statement, Canopy CGC, -1.58% WEED, -7.23%  vice president of communications and media Jordan Sinclair said that the trademark was filed in error and the company does not have a relationship with Young, or “rights to Mr. Young’s name, likeness or any of his intellectual property.” Sinclair said that the company apologizes to Dr. Dre.

See also: Canada’s largest province unveils rules for retail marijuana sales

“Our staff is encouraged to think of new and exciting trademarks,” Sinclair wrote. “In this case, a staff member improperly put this item forward for trademark protection, and while this should have been caught and stopped, it was not. This was a mistake on our part.”

According to the trademark filing, which was reported earlier, one of Canopy’s subsidiaries planned to use it for a range of consumer goods including sunglasses, cannabis products and pet accessories.

Universal Music LLC, which operates Dr. Dre’s Aftermath Entertainment music label as a subsidiary, did not return several emails requesting comment.

Canopy stock was trading 1.3% higher in Friday trading as the S&P 500 indexSPX, +0.00%  fell less than 0.1%. Canopy shares have gained more than 100% this year — much of those gains came after Constellation Brands Inc. STZ, +0.32% announced a $4 billion investment in the company in August.

SPONSORED CONTENT